Drug Approval | April 10, 2024
Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
The facility will manufacture tablets, capsules, and injections for the oncology segment
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
The company intends to respond to the two minor observations within the stipulated time
The company has received five final approvals
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Subscribe To Our Newsletter & Stay Updated
